Telos Capital Management Inc. Cuts Stake in Xylem Inc. (NYSE:XYL)

Telos Capital Management Inc. decreased its holdings in Xylem Inc. (NYSE:XYL) by 7.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,101 shares of the industrial products company’s stock after selling 323 shares during the period. Telos Capital Management Inc.’s holdings in Xylem were worth $469,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Bruce G. Allen Investments LLC purchased a new stake in shares of Xylem in the 4th quarter valued at $27,000. Coppell Advisory Solutions LLC purchased a new stake in shares of Xylem in the 2nd quarter valued at $45,000. KB Financial Partners LLC purchased a new stake in shares of Xylem in the 1st quarter valued at $42,000. NBC Securities Inc. purchased a new stake in shares of Xylem in the 3rd quarter valued at $38,000. Finally, Orion Capital Management LLC purchased a new stake in shares of Xylem in the 3rd quarter valued at $48,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Down 1.4 %

Shares of NYSE XYL opened at $126.22 on Thursday. The company has a current ratio of 1.76, a quick ratio of 1.30 and a debt-to-equity ratio of 0.22. Xylem Inc. has a 12 month low of $87.59 and a 12 month high of $130.86. The firm has a market capitalization of $30.60 billion, a PE ratio of 46.40, a price-to-earnings-growth ratio of 2.55 and a beta of 1.10. The firm has a fifty day simple moving average of $126.85 and a two-hundred day simple moving average of $112.01.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, February 6th. The industrial products company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.96 by $0.03. The business had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.05 billion. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The company’s revenue for the quarter was up 40.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.92 EPS. Equities analysts expect that Xylem Inc. will post 4.13 earnings per share for the current year.

Xylem Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Investors of record on Wednesday, February 21st were paid a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 1.14%. This is a positive change from Xylem’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, February 20th. Xylem’s dividend payout ratio (DPR) is presently 52.94%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on XYL shares. Robert W. Baird upped their price objective on shares of Xylem from $141.00 to $148.00 and gave the company an “outperform” rating in a research note on Thursday, March 21st. Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 4th. Stifel Nicolaus increased their price target on shares of Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research report on Wednesday, February 7th. Royal Bank of Canada increased their price target on shares of Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Wednesday, February 7th. Finally, BNP Paribas started coverage on shares of Xylem in a research report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 price target for the company. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Xylem currently has a consensus rating of “Moderate Buy” and an average target price of $135.44.

Insider Buying and Selling

In related news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now directly owns 11,750 shares in the company, valued at approximately $1,431,032.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares in the company, valued at approximately $1,431,032.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at $360,682.15. The disclosure for this sale can be found here. 0.27% of the stock is owned by company insiders.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.